LAV
Funding rounds backed by LAV.
- Funding disclosed in full
- $265.2M
- Median round
- $43.8M
- Rounds in calculation
- 4
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Accro Bioscience Develops novel therapeutics for immune mediated diseases | $50MSeries C | BiotechUnited States | |||
| Syneron Bio Develops intelligent platform-driven macrocyclic peptide drug discovery | $150MSeries B | BiotechChina | |||
| Excalipoint Therapeutics Develops next-generation T-cell engager therapies for cancer and autoimmune diseases | $27.7MSeed+ | BiotechChina | |||
| Caldera Therapeutics Develops bispecific antibody CLD-423 for inflammatory bowel disease | $37.5MSeries A1 | BiotechUnited States |